SebastianAshford

Associate

Perth + 61.8.6214.5744

Sebastian Ashford joined our New Lawyers Group (NLG) in 2020. The NLG provides our newest lawyers with the opportunity to gain exposure to different practice areas and lawyering styles before making a commitment to a specific practice. Individuals in the NLG may focus on a particular area of practice, or compare practices, during their first year with Jones Day.

Experience

  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health on the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • Global medical devices company receives advice regarding performance management of employeeJones Day advised the Australian subsidiary of a multinational medical devices company on the protracted performance management and negotiated termination of employment of one of its employees, including drafting and negotiating a Deed of Release.
  • PTTGC acquires allnex from AdventJones Day is advising PTT Global Chemical Public Company Limited in the €4 billion acquisition of allnex Holding GmbH from Advent International.
  • Government-owned investment company investigates allegations of inappropriate workplace conduct by senior employeeJones Day advised a government-owned investment company in relation to a confidential workplace investigation into allegations of inappropriate behavior by a senior employee, including recommended disciplinary action.
  • Multinational software company carries out investigation into workplace bullying by two senior Australian employeesJones Day is advising a multinational software company in relation to allegations of workplace bullying against senior Australian employees, including overseeing the conduct of a third party workplace investigation and advising on subsequent disciplinary action.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • Orocobre to merge with Galaxy Resources to form top five global lithium chemicals companyJones Day is advising Orocobre Limited (Orocobre), an ASX and TSX-listed global lithium carbonate supplier with operations in Argentina, on its merger-of-equals with Galaxy Resources Limited (Galaxy), an ASX-listed global lithium company with operations in Australia, Argentina, and Canada, to create a top five global lithium chemicals company (by market capitalization).
  • FuseFX acquires Rising Sun PicturesJones Day advised FuseFX, a portfolio company of EagleTree Capital, in connection with the acquisition and financing of Rising Sun Pictures, a world-renowned, high-end visual effects studio headquartered in Adelaide, Australia.
  • Procter & Gamble acquires VOOSTJones Day advised The Procter & Gamble Company in its acquisition of VOOST Vitamins, Australia's leading effervescent supplements brand.
  • MAAS Group Holdings Limited (MAAS) completes A$145.6 million IPO on Australian Securities ExchangeJones Day advised MAAS Group Holdings Limited (MAAS) in connection with its A$145.6 million initial public offering on the Australian Securities Exchange (ASX).
  • Five9 acquires Inference Technologies GroupJones Day advised Five9, Inc. in its acquisition of Inference Technologies Group, Inc., a leading global provider of Intelligent Virtual Agents for sales and service organizations.